Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) is a publicly traded Healthcare sector company. As of July 26, 2026, LIXT trades at $7.21 with a market cap of $125.36M and a P/E ratio of 0.00. LIXT moved -5.80% today. Year to date, LIXT is +71.26%; over the trailing twelve months it is +256.93%. Its 52-week range spans $0.64 to $8.38. Rallies surfaces LIXT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Lixte Completes Merger with Nomad, Issues 2.99M Shares, Renames to Nomad Power Solutions: Lixte completed its merger with Nomad Transportable Power Systems, issuing 2,992,041 common shares and 50,366.07 Series D preferred shares convertible into 50,366,070 common shares. The company will rename to Nomad Power Solutions on July 3 and adopt ticker NMAD on July 6 to target a multi-billion-dollar BESS market.
| Metric | Value |
|---|---|
| Price | $7.21 |
| Market Cap | $125.36M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.38 |
| 52-Week Low | $0.64 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-6.01M |
| Gross Margin | 0.00% |
LIXT analyst coverage data. Average price target: $0.00.